The use of a slow release GnRH-agonist implant in female ferrets in season for oestrus suppression;Der Einsatz eines Slow Release GnRH-Agonist Implantats bei östrischen Frettchenfähen zur Ranzunterdrückung

Schweizer Archiv fur Tierheilkunde

Volumn 154, Issue 11, 2012, Pages 487-491

  Goericke Pesch, Sandra ^a   Wehrend, A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Deslorelin; Downregulation; Ferret; Induced ovulation; Oestrus suppression

Indexed keywords

DESLORELIN; DRUG DERIVATIVE; ESTROGEN; GONADORELIN; TRIPTORELIN;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; DRUG IMPLANT; DRUG POTENTIATION; ESTRUS; FEMALE; FERRET;

ANIMALS; DRUG IMPLANTS; ESTROGENS; ESTRUS; FEMALE; FERRETS; GONADOTROPIN-RELEASING HORMONE; TRIPTORELIN PAMOATE;

MUSTELA;

EID: 84868530369     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281/a000392     Document Type: Article

References (30)

1. Baumgärtner W., Juchem R.: Aplastic anemia in ferrets. Tierärztl. Prax. 1987, 15: 333-335.
2. Blatchley F. R., Donovan B. T.: Periphera l plasma progestin levels during anoestrus, oestrus and pseudopregnancy and following hypophysectomy in ferrets. J. Reprod. Fertil. 1972, 31: 331-333.
3. Blatchley F. R., Donovan B. T.: Progesterone secretion during pregnancy and pseudopregnancy in the ferret. J. Reprod. Fertil. 1976, 46: 455-45 6.
4. Carroll R. S., Erskine M. S., Doherty P. C., Lundell L. A., Baum M. J.: Coital stimuli controlling luteinizing hormone secretion and ovulation in the female ferret. Biol. Reprod. 1985, 32: 925-933.
5. Cooper J. E., Brearley M. J., Cunningham A.: Oestrus-associated anaemia in the ferret. Vet. Rec. 1985, 117: 395-396.
6. Fox J. G., Bell J. A.: Growth, reproduction, and breeding. In: Biology and Diseases of the Ferret. Hrsg. J. G. Fox. Williams and Wilkins. 1998, 211-227.
7. Goericke-Pesch S., Georgiev P., Antonov A., Albouy M., Wehrend A.: Clinical effi cacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Theriogenology 2011, 75: 803-810.
8. Goericke-Pesch S., Wilhelm E., Hoffmann B. a.: Hormonelle Downregulation der Hodenfunktion bei Rüde und Kater, eine retrospektive Studie. Pr akt. Tierarzt 2010, 91: 563-570.
9. Goericke-Pesch S., Wilhelm E., Ludwig C., Desmoulins P. O., Driancourt M. A., Hoffmann B. b.: Evaluation of the clinical effi cacy of Gonazon i mplants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. Theriogenology 2010, 73: 920-926.
10. Hammond J., Marshall F. H. A.: Estrus and pseudopregnancy in ferret. Proc. Roy. Soc. Biol. Sci. 1930, 105: 607-630.
11. Hammond J., Walton A.: Not es on ovulation and fertilization in the ferret. J. Exp. Biol. 1934, 14: 307-319.
12. Heap R. B., Hammond J. Jr.: Plasm a progesterone levels in pregnant and pseudopregnant ferrets. J. Reprod. Fertil. 1974, 39: 149-152.
13. Hoffmann B., Höveler R., Hasan S. H., Failing K.: Ovarian and pituitary function in the dog after hysterectomy. J. Reprod. Fertil. 1992, 96: 837-845.
14. Junaidi A., Williamson P. E., Cummins J. M., Martin G. B., Blackberry M. A., Trigg T. E.: Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. Reprod. Fertil. Dev. 2003, 15: 317-322.
15. Junaidi A., Williamson P. E., Martin G. B., Stanton P. G., Blackberry M. A., Cummins J. M., Trigg T. E.: Pituitary and testicular endocrine response s to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants. Reprod. Fertil. Dev. 2007, 19: 891-898.
16. Lindeberg H.: Reproduction of the female ferret (Mustela putorius furo). Reprod. Dom. Anim. 2008, 43, Suppl 2: 150-156.
17. Ludwig C., Desmoulins P. O., Driancourt M. A., Goericke-Pesch S., Hoffmann B.: Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant 'Gonazon', a preclinical trial. Theriogenology 2009, 71: 1037-1045.
18. Marshall F. H. A.: The estrous cycle in the common ferret. Quart. J. Microsc. Sci. 1904, 48: 323-345.
19. Marston J. H., Kelly W. A.: Contraceptive action of intrauterine devices in the ferret. J Reprod. Fertil. 1969, 18: 419-429.
20. Mead R. A., Joseph M. M., Neirinckx S.: Optimal dose of human chorionic gonadotropin for inducing ovulation in the ferret. Zoo. Biol. 1988, 7: 263-267.
21. Oxenham M.: Oestrus control in the ferret. Vet. Rec. 1990, 126: 148.
22. Poole T. B.: Aggressive play in polecats. Symp. Zool. Soc. London 1966, 18: 23-44.
23. Proháczik A., Kulcsár M., Trigg T., Driancourt M. A., Huszenicza G.: Comparison of four treatments to suppress ovarian activity in ferrets (Mustela putorius furo). Vet. Rec. 2010, 166: 74-78.
24. Quesenberry K. E., Carpenter J. W.: Ferrets-Basic anatomy, physiology and husbandry. In: Ferrets, rabbits and rodents. Hrsg. K. E. Quesenberry und J. W. Carpenter, Saunders, Philadelphia, 2004, 9-10.
25. Romagnoli S., Concannon P. W.: Clinical use of progestins in bitches and queens: a review. In: Recent advances in small animal reproduction. Hrsg. P. W. Concannon, G. England, J. Verstegen und C. Linde-Forsberg. International Veterinary Information Service, Ithaca NY. www.ivis.org. 2001.
26. Rosenthal K. L., Peterson M. E., Quesenberry K. E., Hillyer E. V., Beeber N. L., Moroff S. D.: Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991). J. Am. Vet. Med. Assoc. 1993, 203: 271-275.
27. Schoemaker N. J., Schuurmans M., Moorman H., Lumeij J. T.: Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J. Am. Vet. Med. Assoc. 2000, 216: 195-197.
28. Schoemaker N. J., van Deijk R., Muijlaert B., Kik M. J., Kuijten A. M., de Jong F. H., Trigg T. E., Kruitwagen C. L., Mol J. A.: Use of a gonadotropin releasing hormone agonist implant as an alternative for surgical castration in male ferrets (Mustela putorius furo). Theriogenology 2008, 70: 161-167.
29. Trigg T. E., Wright P. J., Armour A. F., Williamson P. E., Junaidi A., Martin G. B., Doyle A. G., Walsh J.: Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J. Reprod. Fertil. 2001, Suppl 57: 255-261.
30. Villars T. A., Erskine M. S., Lambert G. M., Jacobson D., Weaver C. E., Baum M. J.: Endocrine correlates of mating-induced reductions in estrous behaviour in an induced ovulator, the ferret. Horm. Behav. 1980, 24: 198-214.